$MASI — HOLD 📊 | 6 MONTHS THESIS

🎯 FQ2 FY2026 (ends Jun) | reported Aug 04 | Adj EPS $1.41 vs $1.41 ➖ 💡 There is no expectational gap to exploit. The entire pre-deal gap (unaffected price ~$130.15 on Feb 13,2026 vs $180 deal value, roughly a 38% premium) was resolved via the shareholder vote and subsequent closing. 🏢 Business Quality: 8/10 📊 Valuation: $180/share cash was a strategic takeout price: ~15x 2027E EBITDA including Danaher's projected $125M+ annual cost synergies, which was a full control... 🔮 Catalyst: Event/timing: merger closing (expected H2 2026, achieved ~June 2026). Metric: cash consideration of $180/share delivered. Failure condition: regulatory block or deal termination, which did not materialize. No forward catalyst exists for a delisted ticker. ⚖️ Do not trade MASI on a 6-month horizon. Danaher's $180/share all-cash acquisition of Masimo closed in early June 2026, shareholders received cash, and the stock is delisted. No entry, no stop, no target: correct action is to remain in cash / watchli

🎯 FQ2 FY2026 (ends Jun) | reported Aug 04 | Adj EPS $1.41 vs $1.41 ➖